|
Number of women screened
|
10,055
|
212,514
|
258,635
|
220,897
|
170,717
|
232,509
|
159,273
|
|
Number of women with detected breast cancer
|
48
|
1,053
|
1,220
|
1,153
|
935
|
1,662
|
974
|
|
Breast cancer detection rate
|
4.8
|
5.0
|
4.7
|
5.2
|
5.5
|
7.1
|
6.1
|
|
Number of women undergoing further assessment
|
1,768
|
46,973
|
56,961
|
44,919
|
33,135
|
39,921
|
30,239
|
|
Further assessment rate
|
17.6%
|
22.1%
|
22.0%
|
20.3%
|
19.4%
|
17.2%
|
19.0%
|
|
Number of women recalled for further assessment
|
557
|
12,095
|
11,535
|
9,735
|
6,496
|
8,888
|
6,246
|
|
Recall rate
|
5.5%
|
5.7%
|
4.5%
|
4.4%
|
3.8%
|
3.8%
|
3.9%
|
|
Women undergoing open biopsy - benign result
|
21
|
504
|
343
|
226
|
135
|
166
|
90
|
|
Women undergoing open biopsy - malignant result
|
43
|
867
|
992
|
994
|
787
|
1,382
|
784
|
|
Benign to malignant open biopsy ratio
|
0.49
|
0.58
|
0.35
|
0.23
|
0.17
|
0.12
|
0.11
|
|
Number of women with detected breast cancer (cases preceded by neoadjuvant therapy excluded)
|
48
|
1,031
|
1,182
|
1,116
|
905
|
1,610
|
924
|
|
Advanced cases (TNM II+)
|
17
|
331
|
384
|
367
|
284
|
465
|
277
|
|
Advanced cases proportion
|
35.4%
|
32.1%
|
32.5%
|
32.9%
|
31.4%
|
28.9%
|
30.0%
|
|
Invasive cases
|
41
|
933
|
1,072
|
1,023
|
823
|
1,459
|
850
|
|
Invasive cases proportion
|
85.4%
|
90.5%
|
90.7%
|
91.7%
|
90.9%
|
90.6%
|
92.0%
|
|
Node-negative invasive cases
|
27
|
572
|
682
|
644
|
525
|
909
|
535
|
|
Proportion among invasive
|
65.9%
|
61.3%
|
63.6%
|
63.0%
|
63.8%
|
62.3%
|
62.9%
|
|
Invasive ≤ 10 mm cases
|
11
|
312
|
350
|
348
|
288
|
441
|
275
|
|
Proportion among invasive
|
26.8%
|
33.4%
|
32.6%
|
34.0%
|
35.0%
|
30.2%
|
32.4%
|
